Tyra Biosciences, Inc. (TYRA)
NASDAQ·Healthcare·Biotechnology
$31.11
+0.73%
Mkt Cap $1.84B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (15 analysts)
$50.50
Range $42.00 – $59.00
Implied Upside
+62.4%
Consensus $50.50 vs current $31.11
NASDAQ·Healthcare·Biotechnology
$31.11
+0.73%
Mkt Cap $1.84B
Buy
7
Hold
0
Sell
0
Price Target (15 analysts)
$50.50
Range $42.00 – $59.00
+62.4%
Consensus $50.50 vs current $31.11